Workflow
Clover Health (CLOV) Jumps 19.4% on “Buy” Reco

Group 1 - Clover Health Investments, Corp. (NASDAQ:CLOV) experienced a significant stock price increase of 19.37% on a recent Friday, closing at $3.82 per share, driven by a "buy" recommendation from Zacks Research [1] - Zacks Research upgraded Clover Health to "buy" due to an upward trend in earnings estimates, which is a critical factor influencing stock prices [1] - For the fiscal year ending December 2025, Clover Health is projected to earn $0.10 per share, consistent with the previous year's reported figure, while analysts have raised their earnings estimates by 25% over the past three months [2] Group 2 - Clover Health is expected to release its third quarter financial and operating highlights on November 6, 2025, based on historical reporting dates [3]